AzTrials
AzTrials

StrokeNCT07719517

Morning Activation to Improve Mood After Stroke

A study testing Morning Activation Program and Health Education Program in people with Stroke and Depressive Symptoms, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This pilot randomized controlled trial will evaluate the feasibility and preliminary effects of a six-week behavioral intervention designed to improve mood and daily functioning in adults who have experienced a stroke and report depressive symptoms and difficulty becoming engaged in activities after waking. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke, Depressive Symptoms
What is being tested?
Morning Activation Program and Health Education Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteHong Kong
Study dates
15 May 2026to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 years or older.
  • History of stroke at least 6 months before enrollment.
  • Patient Health Questionnaire-9 score of 10 or higher.
  • Difficulty getting started or engaging in activities in the morning.
  • Able to provide informed consent.

Who cannot join

  • Conditions that would interfere with study participation.
  • Neurological condition other than stroke.
  • Currently receiving psychological therapy for depression.
  • Significant cognitive impairment or dementia.
  • Current or past diagnosis of psychosis, bipolar disorder, or mania.
  • Hospitalization that would interfere with study participation.
Show all 9Show fewer
  • Acute or significant suicidal ideation
  • Alcohol or substance use problems within the past month.
  • Use of antidepressant or anti-anxiety medication unless the dosage has been stable for at least 4 weeks and no changes are planned during the study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Hong Kong1 site, 1 recruiting
  • The Hong Kong Polytechnic University

    Hong Kong

    Stephen Lau, +852 2766 4283, chun-lun-stephen.lau@polyu.edu.hk

    Stephen Lau, PhD

    Recruiting

Other trials in Hong Kong

About this study

This pilot randomized controlled trial will evaluate the feasibility and preliminary effects of a six-week behavioral intervention designed to improve mood and daily functioning in adults who have experienced a stroke and report depressive symptoms and difficulty becoming engaged in activities after waking.

Participants will be randomly assigned to either the behavioral intervention or a health education program. Assessments will be completed before and immediately after the six-week program and will include questionnaires and seven-day monitoring of sleep, activity, and mood. The study will also examine feasibility indices such as participant retention, intervention attendance, acceptability, and preliminary changes in mood.

Being tested
Morning Activation Program, Health Education Program
Medical subject headings
Stroke, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Morning Activation ProgramBehavioural

    A six-week individualized behavioral program delivered in weekly sessions of approximately 60 minutes. The program is designed to support engagement in daily activities after waking, establish consistent daily routines, and improve mood and functioning after stroke. Sessions will be tailored to participants' needs and abilities.

  • Health Education ProgramBehavioural

    A six-week health education program delivered in weekly sessions of approximately 60 minutes. The program will provide general information relevant to health and recovery after stroke and will be matched to the experimental program in session frequency and duration. It will not include the individualized behavioral strategies provided in the experimental arm.

Study groups in NCT07719517
Study groupRoleWhat they receive
Morning Activation ProgramExperimentalParticipants will receive a six-week individualized behavioral program delivered in weekly sessions of approximately 60 minutes. The program is designed to support engagement in daily activities after waking, establish consistent daily routines, and improve mood and functioning after stroke.
Receives: Behavioral: Morning Activation Program
Health Education ProgramActive comparatorParticipants will receive a six-week health education program delivered in weekly sessions of approximately 60 minutes. The program will provide general information relevant to health and recovery after stroke and will be matched to the experimental program in session frequency and duration. It will not include the individualized behavioral strategies provided in the experimental arm.
Receives: Behavioral: Health Education Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Recruitment Rate

    Number of participants enrolled divided by the number of months of active recruitment.

    Measured: From the start of recruitment until enrollment of the final participant.

  2. Retention Rate

    Number of randomized participants who complete the immediate post-intervention assessment divided by the total number randomized, expressed as a percentage.

    Measured: Immediately after completion of the 6-week intervention

  3. Intervention Attendance

    Number and percentage of scheduled intervention or health education sessions attended by each participant during the 6-week program.

    Measured: Throughout the 6-week intervention period

  4. Intervention Acceptability

    Acceptability of the assigned program assessed using the 4-item Acceptability of Intervention Measure. Each item is rated from 1 to 5, producing a total score ranging from 4 to 20. Higher scores indicate greater intervention acceptability.

    Measured: Immediately after completion of the 6-week intervention

  5. Participants Experiencing Adverse Events

    Number of adverse events considered related or possibly related to study participation.

    Measured: From enrollment through completion of the immediate post-intervention assessment.

Secondary outcomes (1)
  1. Change in Depressive Symptoms

    Depressive symptom severity assessed using the 9-item Patient Health Questionnaire-9. Total scores range from 0 to 27, with higher scores indicating more severe depressive symptoms.

    Measured: Baseline and immediately after completion of the 6-week intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jul 2026
  2. Study start15 May 2026
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07719517
Sponsor's protocol ID
HSEARS20260321001
Status last verified
Jul 2026
First submitted
17 Jul 2026
Last updated
22 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Morning Activation Program and Health Education Program in people with Stroke and Depressive Symptoms, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Stephen Lau (+852 2766 4283, chun-lun-stephen.lau@polyu.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Recruitment Rate (time frame: From the start of recruitment until enrollment of the final participant.). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in